Daniel K. Spiegelman - Jun 3, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Nathan A. Smith For: Daniel K. Spiegelman
Stock symbol
MYGN
Transactions as of
Jun 3, 2021
Transactions value $
$0
Form type
4
Date filed
6/4/2021, 07:11 PM
Previous filing
Jun 1, 2021
Next filing
Jun 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +12.8K +95.74% $0.00 26.3K Jun 3, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant.